APA (7th ed.) Citation

Vogiatzi, F., Winterberg, D., Lenk, L., Buchmann, S., Cario, G., Schrappe, M., . . . Schewe, D. M. (2019). Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia. Blood, 134(8), . https://doi.org/10.1182/blood.2019000904

Chicago Style (17th ed.) Citation

Vogiatzi, Fotini, et al. "Daratumumab Eradicates Minimal Residual Disease in a Preclinical Model of Pediatric T-cell Acute Lymphoblastic Leukemia." Blood 134, no. 8 (2019). https://doi.org/10.1182/blood.2019000904.

MLA (9th ed.) Citation

Vogiatzi, Fotini, et al. "Daratumumab Eradicates Minimal Residual Disease in a Preclinical Model of Pediatric T-cell Acute Lymphoblastic Leukemia." Blood, vol. 134, no. 8, 2019, https://doi.org/10.1182/blood.2019000904.